Hello clinical flow people, Anybody looking at myeloid markers and commenting about changes in the intensity or aberrant expression to support the diagnosis of myelodysplasia? If so, how do you report them in the flow reports? We have an Oncologist who would like to have a base line flow on all his patients who have bone marrows! I would like to collect data on the expression of myeloid markers. Thank you all, Thamarai Saminathan Pathologist University Medical Center at Princeton Princeton, NJ =========================================================== This e-mail transmission and any documents attached hereto contain information from Princeton HealthCare System which is confidential and/or legally privileged. This information is intended only for the use of the individual or entity to which it is addressed, and only for the purpose for which this transmission was made. Any other use, disclosure, copying, distribution, retransmission, or the taking of any action in reliance upon the contents of this information is strictly prohibited. If you are not the intended recipient, you are hereby notified that any disclosure, copying, distribution, retransmission or the taking of any action in reliance upon the contents of this information is strictly prohibited, and that this e-mail transmission and accompanying documents should be returned to Princeton HealthCare System immediately. In this regard, if you have received this e-mail transmission in error, please notify the sender immediately and destroy all copies of the information contained in this transmission.The above signature block is intended for identification purposes only and does not constitute affirmation that a binding contract has been created via this e-mail communication unless expressly so stated within the body of this e-mail transmission. +-##-+ ===========================================================Received on Wed Jan 19 14:58:00 2005
This archive was generated by hypermail 2.1.8 : Sat Jan 14 2006 - 22:03:34 EST